Purchase Order 75F40122P00598

<p>This is a $359,880.23 firm fixed price definitive contract awarded by the Food and Drug Administration (FDA), a civilian agency, to US Data Management, LLC for a pilot project to support the implementation of the Drug Supply Chain Security Act. The contract does not have a set-aside designation. The contract's ultimate completion date is September 15, 2020. No other details about major subcontractors or the agency's broader programs are provided in the information given.</p>

This is a $238,597.26 firm fixed-price delivery order awarded by the Food and Drug Administration (FDA) to Data Federal Corporation, a minority-owned, small disadvantaged business, for the Freedom Application for Shelf-Life Extension Program (SLEP) under the Division of Product Quality Research (DPQR). The contract is part of the FDA's civilian agency programs and has a period of performance through September 4, 2028. This delivery order was placed under Data Federal's existing Multiple Award...

This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Reglink Associates, LLC, a woman-owned small business. The contract provides a site license to deliver a weekly global medical device update, with a total ceiling value of $15,000.00. The contract was awarded on April 10, 2013 and has an ultimate completion date of April 22, 2016. The place of performance is Silver Spring, Maryland. This contract does not have a...

This is a Firm Fixed Price delivery order awarded by the Food and Drug Administration (FDA) to Integrated Behavioral Health, Inc., a for-profit subchapter S corporation. The $1,024,971 contract is for data resources and surveillance reports to support post-marketing monitoring of non-medical use of pharmaceuticals and illicit drug use. The contract has a six-month performance period with a completion date of September 29, 2026. This delivery order is part of a larger $10 million FDA indefinite...

The Food and Drug Administration awarded a $50.8K firm fixed price purchase order to Brightfield Group LLC for an exploratory behavioral economics study, with performance in Calverton, Maryland and an ultimate completion date of June 30, 2025. This modification de-obligates funds, cancels the non-funded second item, and closes out the contract. The award carries no set-aside designation and was issued directly to the prime contractor without identified subcontractors. Brightfield Group LLC is...

This is a $203,074.56 firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Better Direct, LLC, a small business IT solutions provider. The contract is for maintenance support renewal, with a period of performance through May 11, 2023. Better Direct is a HUBZone, small disadvantaged, veteran-owned, and service-disabled veteran-owned business that provides a range of IT products and services to federal agencies. This award is not...

<p>The Food and Drug Administration issued a delivery order to Label Insight, Inc. on August 1, 2016, with a ceiling value of $338,080.32 for an enhanced license product.</p> <p>Place of performance is Rockville, Maryland. The order was firm fixed price with an ultimate completion date of September 29, 2020. No set-aside applied to this delivery order.</p>

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Jonq-Ying Lee for $12,000.00. The contract is for a statistical assessment of the relationships between nutrition information and diet quality over time. It does not have a set-aside designation. The award date was August 30, 2013, and the ultimate completion date is March 3, 2015.</p>

The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $959,700 firm fixed price delivery order contract to Label Insight, Inc. for food and cosmetic database support and services. The one-year contract, with a period of performance from August 11, 2020 to September 29, 2021, will provide Label Insight's database solutions to support HHS FDA programs in Silver Spring, Maryland. No subcontractors or set aside designations were identified. This order for...

The Food and Drug Administration (FDA), an agency of the Department of Health and Human Services (HHS), awarded a $323,485.46 Blanket Purchase Agreement (BPA) Call contract to Brillient Corporation, doing business as Brillient Corp., to provide Medical Expert Services to analyze adverse event reports and support the strategic development of compliance and enforcement targets for FDA-regulated commodities containing cannabidiol (CBD) and tetrahydrocannabinol (THC). The single-award contract...